Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1590
https://www.valueinhealthjournal.com/article/S1098-3015(18)31896-5/fulltext
Title :
Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31896-5&doi=10.1016/j.jval.2018.04.1590
First page :
Section Title :
Open access? :
No
Section Order :
817